Literature DB >> 27643652

Vaginal Radical Trachelectomy for Early-Stage Cervical Cancer: Increased Recurrence Risk for Adenocarcinoma.

Petra L M Zusterzeel1, Fraukje J M Pol, Maaike van Ham, Ronald P Zweemer, Ruud L M Bekkers, Leon F A G Massuger, René H M Verheijen.   

Abstract

OBJECTIVE: To evaluate consecutive vaginal radical trachelectomies (VRTs) in early-stage cervical cancer in the 2 main referral centers for fertility-preserving surgery in the Netherlands.
MATERIALS AND METHODS: Oncology, fertility, and obstetrical data were recorded in a regional database of all VRTs without neoadjuvant chemotherapy performed in 2 major referral centers between 2000 and 2015.
RESULTS: Most of the patients (91.7%) had stage IB1 disease. In 72.0%, squamous cell carcinoma was the histologic diagnosis; in 24.2%, adenocarcinoma; and in 3.8%, adenosquamous carcinoma. The median follow-up was 51 months.Nine (6.8%) recurrences occurred, 4 resulting in death of disease (death rate, 3.0%). Recurrence rates were 12.5% for adenocarcinoma, 20% for adenosquamous carcinoma, and 4.2% for squamous cell carcinoma (P < 0.01).From 117 women, data about fertility and obstetrical outcome were obtained. Almost 60% of women attempted to conceive after a VRT. Of these women, 40% needed fertility treatment. A total of 47 pregnancies were established, and a total of 37 children were born of which 30 (81.1%) were delivered after 32 weeks of gestational age.
CONCLUSIONS: Nonsquamous cell histology and high-grade disease are associated with a significantly higher risk of recurrence in the univariate and multivariate analyses. Women with both these histology features should be counseled reticently for VRT.Pregnancies after VRT must be regarded as high-risk pregnancies with a high prematurity rate.

Entities:  

Mesh:

Year:  2016        PMID: 27643652     DOI: 10.1097/IGC.0000000000000763

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  7 in total

1.  Preservation of Fertility or Ovarian Function in Patients with Breast Cancer or Gynecologic and Internal Malignancies.

Authors:  Angrit Stachs; Steffi Hartmann; Bernd Gerber
Journal:  Geburtshilfe Frauenheilkd       Date:  2017-08-24       Impact factor: 2.915

2.  Fertility preservation treatment of gynecological cancer patients in Spain: a national survey (GOFER study).

Authors:  Mikel Gorostidi; Blanca Gil-Ibañez; Sonsoles Alonso; Antonio Gil-Moreno; Alicia Hernandez; Aureli Torné; Ignacio Zapardiel
Journal:  Arch Gynecol Obstet       Date:  2020-03-02       Impact factor: 2.344

3.  Reproductive outcomes following treatment for a gynecological cancer diagnosis: a systematic review.

Authors:  Brigitte Gerstl; Elizabeth Sullivan; Marcus Vallejo; Jana Koch; Maximilian Johnson; Handan Wand; Kate Webber; Angela Ives; Antoinette Anazodo
Journal:  J Cancer Surviv       Date:  2019-04-17       Impact factor: 4.442

4.  Fertility-Sparing Treatment for Young Patients with Early-Stage Cervical Cancer: A Dawn of a New Era.

Authors:  Charalampos Theofanakis; Aristotelis-Marios Koulakmanidis; Anastasia Prodromidou; Dimitrios Haidopoulos; Alexandros Rodolakis; Nikolaos Thomakos
Journal:  Front Surg       Date:  2022-05-06

5.  Fertility-sparing surgery in early-stage cervical cancer: laparoscopic versus abdominal radical trachelectomy.

Authors:  Zuoxi He; Ce Bian; Chuan Xie
Journal:  BMC Womens Health       Date:  2022-06-18       Impact factor: 2.742

6.  Radical Trachelectomy for the Treatment of Early-Stage Cervical Cancer: A Systematic Review.

Authors:  Evan S Smith; Ashley S Moon; Robin O'Hanlon; Mario M Leitao; Yukio Sonoda; Nadeem R Abu-Rustum; Jennifer J Mueller
Journal:  Obstet Gynecol       Date:  2020-09       Impact factor: 7.623

7.  Neoadjuvant Chemotherapy Followed by Vaginal Radical Trachelectomy as Fertility-Preserving Treatment for Patients with FIGO 2018 Stage 1B2 Cervical Cancer.

Authors:  Petra L M Zusterzeel; Johanna W M Aarts; Fraukje J M Pol; Petronella B Ottevanger; Maaike A P C van Ham
Journal:  Oncologist       Date:  2020-05-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.